{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:33:09Z","timestamp":1776954789270,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,18]]},"DOI":"10.7759\/cureus.39207","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:02:11Z","timestamp":1684476131000},"source":"Crossref","is-referenced-by-count":1,"title":["Gout in an Obese Patient with Nonalcoholic Steatohepatitis on a Thiazide Diuretic and Association Between Hyperuricemia and Nonalcoholic Steatohepatitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Zahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amresh","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Gout. (2020). Accessed. May 2, 2023: https:\/\/www.cdc.gov\/arthritis\/basics\/gout.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21772","article-title":"2012 American college of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna D","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, et al.. 2012 American college of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012, 64:1431-46. 10.1002\/acr.21772","journal-title":"Arthritis Care Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew293","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem C","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatology. 2017, 56:679-88. 10.1093\/rheumatology\/kew293","journal-title":"Rheumatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8190","article-title":"Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study","volume":"344","author":"Choi HK","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012, 344:d8190. 10.1136\/bmj.d8190","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3579(05)80295-x","article-title":"Drug-induced gout","volume":"5","author":"Scott J","year":"1991","unstructured":"Scott J. Drug-induced gout. Baillieres Clin Rheumatol. 1991, 5:39-60. 10.1016\/s0950-3579(05)80295-x","journal-title":"Baillieres Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-164","article-title":"The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality","volume":"14","author":"Gustafsson D","year":"2013","unstructured":"Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013, 14:164. 10.1186\/1471-2369-14-164","journal-title":"BMC Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v13n1p103","article-title":"Correlation between uric acid and non-alcoholic steatohepatitis (NASH) occurred in obesity and non-obesity","volume":"13","author":"Rasdiana R","year":"2020","unstructured":"Rasdiana R, Faridin HP, Akil F, et al.. Correlation between uric acid and non-alcoholic steatohepatitis (NASH) occurred in obesity and non-obesity. Glob J Health Sci. 2020, 13:103. 10.5539\/gjhs.v13n1p103","journal-title":"Glob J Health Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.657856","article-title":"Serum uric acid is a mediator of the association between obesity and incident nonalcoholic fatty liver disease: a prospective cohort study","volume":"12","author":"Zhang Q","year":"2021","unstructured":"Zhang Q, Ma X, Xing J, et al.. Serum uric acid is a mediator of the association between obesity and incident nonalcoholic fatty liver disease: a prospective cohort study. Front Endocrinol. 2021, 12:657856. 10.3389\/fendo.2021.657856","journal-title":"Front Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04788.x","article-title":"Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease","volume":"34","author":"Petta S","year":"2011","unstructured":"Petta S, Camm\u00e0 C, Cabibi D, Di Marco V, Crax\u00ec A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011, 34:757-66. 10.1111\/j.1365-2036.2011.04788.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011578","article-title":"High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study","volume":"5","author":"Xu C","year":"2010","unstructured":"Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One. 2010, 5:e11578. 10.1371\/journal.pone.0011578","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01615-w","article-title":"Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease","volume":"21","author":"Zhou M","year":"2021","unstructured":"Zhou M, Yang N, Xing X, et al.. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021, 21:43. 10.1186\/s12876-021-01615-w","journal-title":"BMC Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173525","article-title":"Gout and diet: a comprehensive review of mechanisms and management","volume":"14","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Chen S, Yuan M, Xu Y, Xu H. Gout and diet: a comprehensive review of mechanisms and management. Nutrients. 2022, 14:3525. 10.3390\/nu14173525","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000779","article-title":"The role of diet in hyperuricemia and gout","volume":"33","author":"Yokose C","year":"2021","unstructured":"Yokose C, McCormick N, Choi HK. The role of diet in hyperuricemia and gout. Curr Opin Rheumatol. 2021, 33:135-44. 10.1097\/BOR.0000000000000779","journal-title":"Curr Opin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150310","article-title":"An observational study of gout prevalence and quality of care in a national Australian general practice population","volume":"42","author":"Robinson PC","year":"2015","unstructured":"Robinson PC, Taylor WJ, Dalbeth N. An observational study of gout prevalence and quality of care in a national Australian general practice population. J Rheumatol. 2015, 42:1702-7. 10.3899\/jrheum.150310","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283438e13","article-title":"Risk factors for gout and prevention: a systematic review of the literature","volume":"23","author":"Singh JA","year":"2011","unstructured":"Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011, 23:192-202. 10.1097\/BOR.0b013e3283438e13","journal-title":"Curr Opin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2015.22.132.6447","article-title":"Chronic tophaceous gout with unusual large tophi: case report","volume":"22","author":"Aradoini N","year":"2015","unstructured":"Aradoini N, Talbi S, Berrada K, Abourazzak FZ, Harzy T. Chronic tophaceous gout with unusual large tophi: case report. Pan Afr Med J. 2015, 22:132. 10.11604\/pamj.2015.22.132.6447","journal-title":"Pan Afr Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101051","article-title":"Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review","volume":"4","author":"Gill I","year":"2020","unstructured":"Gill I, Dalbeth N, 'Ofanoa M, Goodyear-Smith F. Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review. BJGP Open. 2020, 4:10.3399\/bjgpopen20X101051","journal-title":"BJGP Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2010.4.3.378","article-title":"Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study","volume":"4","author":"Lee JW","year":"2010","unstructured":"Lee JW, Cho YK, Ryan M, et al.. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010, 4:378-83. 10.5009\/gnl.2010.4.3.378","journal-title":"Gut Liver"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157459-gout-in-an-obese-patient-with-nonalcoholic-steatohepatitis-on-a-thiazide-diuretic-and-association-between-hyperuricemia-and-nonalcoholic-steatohepatitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:19Z","timestamp":1707508879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157459-gout-in-an-obese-patient-with-nonalcoholic-steatohepatitis-on-a-thiazide-diuretic-and-association-between-hyperuricemia-and-nonalcoholic-steatohepatitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.39207","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}